LYKA LABS
Back to Balance Sheet
|
LYKA LABS Last 5 Year Total Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹175 Cr | ₹176 Cr | ₹157 Cr | ₹152 Cr | ₹186 Cr |
What is the latest Total Liabilities ratio of LYKA LABS ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹175 Cr |
| Mar2025 | ₹176 Cr |
| Mar2024 | ₹157 Cr |
| Mar2023 | ₹152 Cr |
| Mar2022 | ₹186 Cr |
How is Total Liabilities of LYKA LABS Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹175 Cr | -0.95 | |
| Mar2025 | ₹176 Cr | 12.33 | |
| Mar2024 | ₹157 Cr | 3.52 | |
| Mar2023 | ₹152 Cr | -18.37 | |
| Mar2022 | ₹186 Cr | - | |
Compare Total Liabilities of peers of LYKA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LYKA LABS | ₹238.9 Cr | 10.3% | -4.7% | -42.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹470,270.0 Cr | -1.5% | 2.5% | 14.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹222,224.0 Cr | 7.4% | 22.2% | 26.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,325.0 Cr | 3.1% | 4.3% | 38.5% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | -1.6% | -1.4% | -6.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,876.6 Cr | 1.5% | -15.2% | -9.1% | Stock Analytics | |
LYKA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LYKA LABS | 10.3% |
-4.7% |
-42.3% |
| SENSEX | 2.2% |
0.9% |
-3.7% |
You may also like the below Video Courses